All News | RheumNow

All News

TNR041823

TNR: Private Practice & Academia

Save

d Kathryn H. Dao, M.D.

Apr 19, 2023

In this session, our panelists addressed the big questions of: "How do I choose between private practice and academia?" and "How do I advance in my career?".

Read Article

renal.genes_.jpg

Renal Function Safe With Pegloticase-MTX Combo for Gout

Save

d MedPage Today

Apr 18, 2023

For patients with uncontrolled gout, estimated glomerular filtration rate (eGFR) remained stable with combination pegloticase (Krystexxa) and methotrexate treatment, researchers reported.

Read Article

Success Leader Growth

Women Rheumatologists Leading in the Private Sector

Save

d Priya Reddy, MD, FACR

Apr 18, 2023

Women physician leaders have made significant contributions in various fields, such as business leaders as CEOs and board members, public health through national and international advocacy efforts, and the non-profit sector.

"To Lead or Not To Lead" - that is the question.

Read Article

arthritis.RA_.Xray_.hands_.jpg (keep)

Immune Checkpoint Inhibitor Safety with Pre-existing Rheumatoid Arthritis

Save

d Jack Cush, MD

Apr 17, 2023

Lancet Rheumatology has published a retrospective analysis showing patients receiving immune checkpoint inhibitors (ICI) for cancer have the same outcomes (mortality and severe immune-related adverse events (irAEs)) even when they have pre-existing rheumatoid arthritis (RA).

Read Article

Immune Checkpoint Inhibitor Safety with Pre-existing Rheumatoid Arthritis Lancet Rheumatology has published a retrospective analysis showing patients receiving ICI for cancer have the same outcomes even when they have pre-existing RA. https://t.co/Tjj827nPTT https://t.co/nBBgI9wpjR

Links:

https://bit.ly/43J9vZy

Dr. John Cush RheumNow ( View Tweet)

Apr 19, 2023

Brigham review (2018-2022) of 47 CPPD pts: M=F, mean age 72 yrs 68% w/ acute CPP arthritis 40% w/ CPP inflammatory arthritis 62% w/ OA with CPPD. Compared to Gout, CPPD Significant unmet Rx need & lower RAPID3 (8.1 vs 12.1) https://t.co/nFOW4FS0fp https://t.co/3n6WTg66r8

Links:

https://bit.ly/41FFnfH

Dr. John Cush RheumNow ( View Tweet)

Apr 19, 2023

What do we know about gender equity in academic rheumatology? Dr. Nicola Dalbeth (@NicolaDalbeth) shares her thoughts. https://t.co/ha4UvqEygk https://t.co/tmGhFUW09t

Links:

https://bit.ly/3LduPPJ

Dr. John Cush RheumNow ( View Tweet)

Apr 19, 2023

RheumThoughts: The Benefits of Networking Dr. Rachel Tate ( @uptoTate ) discusses the importance and benefits of networking. RheumThoughts are opinion pieces from healthcare professionals in the RheumNow network. https://t.co/Ug3N4F4CGI https://t.co/vpXSsrlCcd

Links:

https://bit.ly/3L5iYTJ

Dr. John Cush RheumNow ( View Tweet)

Apr 18, 2023

6 specialties saw a pay drop in 2023 - #6 on the list was Rheumatology at -3% (based on Medscape survey of 10,011 physicians 1022-1/23. Biggest drop was Ophthalmology -7% (then EM -6%, PM&R -5%, Nephrology -5%, Allergy -5%, RHEUM -3%) https://t.co/9P7ujh2Tw0 https://t.co/8DaGUsrROY

Links:

https://bit.ly/40gwmsg

Dr. John Cush RheumNow ( View Tweet)

Apr 18, 2023

Study of 9558 pts found significant associations betw migraine and CTS Median nerve decompression (OR, 1.3) & multiple nerve decompressions (OR, 1.7). Also assoc w/ migraine: psych dz, RA, CVS, hypothyroid, HTN, COPD https://t.co/cIdkACHGwB https://t.co/VO3VqujzSQ

Links:

https://bit.ly/3A5khf3

Dr. John Cush RheumNow ( View Tweet)

Apr 18, 2023

Real world interchangeabilty study compared rituximab to biosimilar ( CT-P10) in 128 Rheum pts (CT-P10= 64; RTX= 64), with 41% of pts switched from RTX to CT-P10. Both Rx had Comparable Gr 2 infuxion Rxs, infection #s & hypogammaglobulinemia (p > 0.05) https://t.co/RNxt7Xn7MJ https://t.co/u3yJNQQIMC

Links:

https://bit.ly/41BAFzQ

Dr. John Cush RheumNow ( View Tweet)

Apr 18, 2023

Doctor’s Contracts: Pitfalls and Traps Dr. Dao ( @KDAO2011) spoke with Andrea Liberatore, JD, to explain what to look for in a contract. https://t.co/w44pWWyhpo https://t.co/fy5vlve4IQ

Links:

https://bit.ly/43vU6eW

Dr. John Cush RheumNow ( View Tweet)

Apr 17, 2023

Retrospective study on prescribing by male vs female RHEUMs, found that women (in private practice, >10 yrs) were less likely to be High steroid prescribers. RA Pts more likely to Rx steroids = male sex, >prior biologics, opioid use, w/ comorbidities & freq infx https://t.co/eO3yJRCfOR

Dr. John Cush RheumNow ( View Tweet)

Apr 17, 2023

The European Commission has approved upadacitinib (Rinvoq) for the Treatment of Moderately to Severely Active Crohn's Disease https://t.co/Clzca7jU5b https://t.co/nNFGe5fF25

Links:

https://bit.ly/3MKJtPz

Dr. John Cush RheumNow ( View Tweet)

Apr 17, 2023

12 mos. serial study of 71 pts with gout found 42% with at least 1 gout flare (median=2) over 12 mos. US eval. showed "Flare" pts had signif more MSU deposits (6.7 vs 2.9) & power Doppler (3.73 vs 0.82)vs controls. By US- were 17-29% more likely to flare. https://t.co/icDyNEsCa6 https://t.co/86pgBzG9MC

Links:

https://bit.ly/43Gx59m

Dr. John Cush RheumNow ( View Tweet)

Apr 17, 2023

Lillys IL-23 inhibitor (Mirakizumab) has suffered a minor setback receiving a "complete response letter" from the FDA regarding MIRA application (BLA) for use in ulcerative colitis. The CRL hold up is related to the manufacturing issues (not data/safety) https://t.co/Xs93pFNFAp https://t.co/vlVP8qiqGr

Links:

https://yhoo.it/3MLB5PT

Dr. John Cush RheumNow ( View Tweet)

Apr 17, 2023

Pain and Opioid Updates The CDC and FDA provided new updates on the scope of pain in the USA and guidance on the use of opioids. https://t.co/jjN9zvX7rV https://t.co/kY3kX1S8vq

Links:

https://bit.ly/3A497XV

Dr. John Cush RheumNow ( View Tweet)

Apr 17, 2023

Retrospective study of 147 THA and TKA pts w/ acute/chronic complaint - 39 pts Dx w/ prosthetic joint infection (PJI). Absolute numbers of neutrophils (PMNs) best predicted PJI (THA > 3,600 PMN/µl; TKA >2,000 PMN/µl (sensitivity 97%; specificity 93.5%) https://t.co/pxKcsTT6tn https://t.co/IQZ0DSUxwc

Links:

https://bit.ly/3oknDIz

Dr. John Cush RheumNow ( View Tweet)

Apr 17, 2023

Best Treatments for Immune Checkpoint Inhibitor-associated Arthritis A retrospective study of cancer patients who developed ICI-IA shows that biologic DMARDs were more effective than csDMARDs in rapid control of arthritis. https://t.co/EQjSgav0by https://t.co/CZ0IqR3UXM

Links:

https://bit.ly/3UDiasg

Dr. John Cush RheumNow ( View Tweet)

Apr 17, 2023

Clinical Profile of RA-associated Interstitial Lung Disease A prospective, cross-sectional analysis of patients with rheumatoid arthritis (RA) shows those with interstitial lung disease (ILD) tend to be older, obese and have a smoking history. https://t.co/FazEGcHh5H https://t.co/oh6oIpj21k

Links:

https://bit.ly/3oajdDX

Dr. John Cush RheumNow ( View Tweet)

Apr 17, 2023

×